Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June-2023 Volume 25 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2023 Volume 25 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review)

  • Authors:
    • Yuxin Xie
    • Qiyan Deng
    • Menglu Guo
    • Xiaolong Li
    • Deihai Xian
    • Jianqiao Zhong
  • View Affiliations / Copyright

    Affiliations: Department of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China, Department of Neurobiology, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China
    Copyright: © Xie et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 300
    |
    Published online on: May 9, 2023
       https://doi.org/10.3892/etm.2023.11999
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Henoch‑Schonlein purpura (HSP), a recurrent and immunoglobulin (Ig)A‑mediated vasculitis, presents not only as skin lesions but also as systemic involvement that can be life‑threatening. Although the etiology of HSP remains unknown, immune imbalance and oxidative stress (OS) are primary contributors to its pathogenesis, alongside the abnormal activation of Toll‑like receptor (TLR)/myeloid differentiation primary response gene 88 (MyD88)/nuclear factor‑κB (NF‑κB) pathway. TLRs, especially TLR4, stimulate downstream signaling molecules such as NF‑κB and proinflammatory cytokines, which are released when TLRs combine with the key adapter molecule MyD88. This leads to the activation of T helper (Th) cell 2/Th17 and overproduction of reactive oxygen species (ROS). The function of regulatory T (Treg) cells is suppressed in the process. Th17/Treg imbalance then produces various inflammatory cytokines to promote proliferation and differentiation of B cells and the secretion of antibodies. IgA is secreted, and it binds to vascular endothelial surface receptors where the complex induces injury of the vascular endothelial cells. Additionally, excessive ROS creates OS that leads to an inflammatory response and vascular cell apoptosis or necrosis, thereby contributing to vascular endothelial damage and HSP occurrence. Proanthocyanidins are active compounds naturally enriched in fruits, vegetables and plants. Proanthocyanidins have diverse properties, including anti‑inflammatory, antioxidant, antibacterial, immunoregulatory, anticarcinogenic and vascular protective effects. Proanthocyanidins are used in the management of various diseases. Proanthocyanidins regulate T cells, equilibrate immunity and arrest OS by inhibiting the TLR4/MyD88/NF‑κB signaling pathway. Considering the pathogenesis of HSP and the properties of proanthocyanidins, the present study hypothesized that these compounds may potentially lead to HSP recovery through modulating the immune equilibrium and preventing OS by inhibiting the TLR4/MyD88/NF‑κB pathway. To the best of our knowledge, however, little is known about the positive effects of proanthocyanidins against HSP. The present review summarizes the potential of proanthocyanidins to treat HSP.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Wang K, Sun X, Cao Y, Dai L, Sun F, Yu P and Dong L: Risk factors for renal involvement and severe kidney disease in 2731 Chinese children with Henoch-Schönlein purpura: A retrospective study. Medicine (Baltimore). 97(e12520)2018.PubMed/NCBI View Article : Google Scholar

2 

Chimenz R, Cannavò L, Spinuzza A, Fede C, Cucinotta U, Pensabene L, Betta P, Gitto E, Concolino D and Cuppari C: Unusual presentation of Henoch-Schönlein purpura. J Biol Regul Homeost Agents. 33 (5 Suppl 1):S69–S74. 2019.PubMed/NCBI

3 

Gómez S, Pérez M, Pellegrini M, Isern E, Quintana C, Artacho P, Bertolini M, Pomerantz B and Gadda N: Henoch-Schonlein purpura in pediatrics: Ten years of experience at a moderate risk office of a general hospital. Arch Argent Pediatr. 118:31–37. 2020.PubMed/NCBI View Article : Google Scholar : (In English, Spanish).

4 

Yang HR: What we know about Henoch-Schönlein purpura in children up to date? J Korean Med Sci. 33(e199)2018.PubMed/NCBI View Article : Google Scholar

5 

Zhu Y, Dong Y, Wu L and Deng F: Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children. BMC Pediatr. 19(409)2019.PubMed/NCBI View Article : Google Scholar

6 

Zhang N, Guo PJ, Liu PL, Yang HR, Xiao J, Li XP, Huang JB and Zheng YZ: Comparison of age-based clinical and abnormal immune parameters in patients with Henoch-Schönlein purpura. Zhonghua Xue Ye Xue Za Zhi. 38:60–64. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).

7 

Niknam N, Ha L and Gautam-Goyal P: Adult onset immunoglobulin A vasculitis (Henoch-Schonlein purpura) with alveolar hemorrhage. IDCases. 12:47–48. 2018.PubMed/NCBI View Article : Google Scholar

8 

Tan J, Tang Y, Zhong Z, Yan S, Tan L, Tarun P and Qin W: The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch-Schönlein purpura nephritis: A meta-analysis. Int Urol Nephrol. 51:975–985. 2019.PubMed/NCBI View Article : Google Scholar

9 

Roman C, Dima B, Muyshont L, Schurmans T and Gilliaux O: Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): Case series and a review of the literature. Eur J Pediatr. 178:1275–1281. 2019.PubMed/NCBI View Article : Google Scholar

10 

Vonend C, Rifkin SI, Baliga RS and Weinstein SS: Henoch-Schönlein purpura and recurrent renal failure. Ren Fail. 32:888–891. 2010.PubMed/NCBI View Article : Google Scholar

11 

Oni L and Sampath S: Childhood IgA vasculitis (Henoch Schonlein Purpura)-advances and knowledge gaps. Front Pediatr. 7(257)2019.PubMed/NCBI View Article : Google Scholar

12 

Fan L, Yan H, Zhen X, Wu X, Hao J, Hou L and Han L: Safety and efficacy evaluation of traditional chinese medicine (Qingre-Lishi-Yishen Formula) based on treatment of regular glucocorticoid combined with cyclophosphamide pulse in children suffered from moderately Severe Henoch-Schonlein Purpura nephritis with nephrotic proteinuria. Evid Based Complement Alternat Med. 2020(3920735)2020.PubMed/NCBI View Article : Google Scholar

13 

Nichols JA and Katiyar SK: Skin photoprotection by natural polyphenols: Anti-inflammatory, antioxidant and DNA repair mechanisms. Arch Dermatol Res. 302:71–83. 2010.PubMed/NCBI View Article : Google Scholar

14 

Tong H, Song X, Sun X, Sun G and Du F: Immunomodulatory and antitumor activities of grape seed proanthocyanidins. J Agric Food Chem. 59:11543–1157. 2011.PubMed/NCBI View Article : Google Scholar

15 

Huang S, Yang N, Liu Y, Hu L, Zhao J, Gao J, Li Y, Li C, Zhang X and Huang T: Grape seed proanthocyanidins inhibit angiogenesis via the downregulation of both vascular endothelial growth factor and angiopoietin signaling. Nutr Res. 32:530–536. 2012.PubMed/NCBI View Article : Google Scholar

16 

Wen W, Lu J, Zhang K and Chen S: Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev Res (Phila). 1:554–561. 2008.PubMed/NCBI View Article : Google Scholar

17 

Wu L, Huang Z, Qin P, Yao Y, Meng X, Zou J, Zhu K and Ren G: Chemical characterization of a procyanidin-rich extract from sorghum bran and its effect on oxidative stress and tumor inhibition in vivo. J Agric Food Chem. 59:8609–8615. 2011.PubMed/NCBI View Article : Google Scholar

18 

Yang L, Xian D, Xiong X, Lai R, Song J and Zhong J: Proanthocyanidins against oxidative stress: From molecular mechanisms to clinical applications. Biomed Res Int. 2018(8584136)2018.PubMed/NCBI View Article : Google Scholar

19 

Mantena SK and Katiyar SK: Grape seed proanthocyanidins inhibit UV-radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling in human epidermal keratinocytes. Free Radic Biol Med. 40:1603–1614. 2006.PubMed/NCBI View Article : Google Scholar

20 

Koudoufio M, Feldman F, Ahmarani L, Delvin E, Spahis S, Desjardins Y and Levy E: Intestinal protection by proanthocyanidins involves anti-oxidative and anti-inflammatory actions in association with an improvement of insulin sensitivity, lipid and glucose homeostasis. Sci Rep. 11(3878)2021.PubMed/NCBI View Article : Google Scholar

21 

Baldivia DDS, Leite DF, Castro DTH, Campos JF, Santos UPD, Paredes-Gamero EJ, Carollo CA, Silva DB, de Picoli Souza K and Dos Santos EL: Evaluation of in vitro antioxidant and anticancer properties of the aqueous extract from the stem bark of stryphnodendron adstringens. Int J Mol Sci. 19(2432)2018.PubMed/NCBI View Article : Google Scholar

22 

Alsharairi NA: Insights into the mechanisms of action of proanthocyanidins and anthocyanins in the treatment of nicotine-induced non-small cell lung cancer. Int J Mol Sci. 23(7905)2022.PubMed/NCBI View Article : Google Scholar

23 

Lau KK, Suzuki H, Novak J and Wyatt RJ: Pathogenesis of Henoch-Schönlein purpura nephritis. Pediatr Nephrol. 25:19–26. 2010.PubMed/NCBI View Article : Google Scholar

24 

Keskin N, Civilibal M, Elevli M, Koldas M, Duru NS and Ozturk H: Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura. Pediatr Nephrol. 26:1989–1993. 2011.PubMed/NCBI View Article : Google Scholar

25 

Xu H, Jiang G, Shen H, Li W, Mao J and Pan Y: Association of TLR4 gene polymorphisms with childhood Henoch-Schönlein purpura in a Chinese population. Rheumatol Int. 37:1909–1915. 2017.PubMed/NCBI View Article : Google Scholar

26 

Canpinar H, Ozaltin F, Bilginer Y, Bakkaloğlu A and Ozen S: Toll-like receptors 2 and 4 cell surface expression reflects endotoxin tolerance in Henoch-Schönlein purpura. Turk J Pediatr. 52:22–27. 2010.PubMed/NCBI

27 

Donadio ME, Loiacono E, Peruzzi L, Amore A, Camilla R, Chiale F, Vergano L, Boido A, Conrieri M, Bianciotto M, et al: Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch-Schönlein purpura and primary IgA nephropathy. Pediatr Nephrol. 29:1545–1551. 2014.PubMed/NCBI View Article : Google Scholar

28 

Chang H, Zhang QY, Lin Y, Cheng N and Zhang SQ: Correlation of TLR2 and TLR4 expressions in peripheral blood mononuclear cells to Th1- and Th2-type immune responses in children with Henoch-Schönlein Purpura. Int J Clin Exp Med. 8:13532–13539. 2015.PubMed/NCBI

29 

Chang H, Yu DS, Liu XQ, Zhang QY, Cheng N, Zhang SQ and Qu ZH: Clinical significance of TLR3 and TLR4 in peripheral blood mononuclear cells from children with Henoch-Schönlein purpura nephritis. Exp Ther Med. 7:1703–1707. 2014.PubMed/NCBI View Article : Google Scholar

30 

Zhou L, Xu F, Chang C, Tao Y, Song L and Li X: Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia. Blood Coagul Fibrinolysis. 27:301–307. 2016.PubMed/NCBI View Article : Google Scholar

31 

Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F and Weil R: NF-κB: At the borders of autoimmunity and inflammation. Front Immunol. 12(716469)2021.PubMed/NCBI View Article : Google Scholar

32 

Yu H, Lin L, Zhang Z, Zhang H and Hu H: Targeting NF-κB pathway for the therapy of diseases: Mechanism and clinical study. Signal Transduct Target Ther. 5(209)2020.PubMed/NCBI View Article : Google Scholar

33 

Oh H and Ghosh S: NF-κB: Roles and regulation in different CD4(+) T-cell subsets. Immunol Rev. 252:41–51. 2013.PubMed/NCBI View Article : Google Scholar

34 

Pandiyan P and Zhu J: Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells. Cytokine. 76:13–24. 2015.PubMed/NCBI View Article : Google Scholar

35 

Chang H, Lin Y, Lei K, Wang F, Zhang QQ and Zhang QY: Role of hypomethylation of suppressor of cytokine signaling in T helper 17 cell/regulatory T cell imbalance in children with Henoch-Schönlein purpura. Zhongguo Dang Dai Er Ke Za Zhi. 21:38–44. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).

36 

Li-Weber M, Giaisi M, Baumann S, Pálfi K and Krammer PH: NF-kappa B synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. Eur J Immunol. 34:1111–1118. 2004.PubMed/NCBI View Article : Google Scholar

37 

Li YY, Li CR, Wang GB, Yang J and Zu Y: Investigation of the change in CD4+ T cell subset in children with Henoch-Schonlein purpura. Rheumatol Int. 32:3785–3792. 2012.PubMed/NCBI View Article : Google Scholar

38 

Yang J, Li CR, Zu Y, Wang GB and Li YB: Role of regulatory T cells in pathogenesis of Henoch-Schonlein purpura in children. Zhonghua Er Ke Za Zhi. 44:411–414. 2006.PubMed/NCBI(In Chinese).

39 

Gujer C, Sundling C, Seder RA, Karlsson Hedestam GB and Loré K: Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation. Immunology. 134:257–269. 2011.PubMed/NCBI View Article : Google Scholar

40 

Ohue Y and Nishikawa H: Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Cancer Sci. 110:2080–2089. 2019.PubMed/NCBI View Article : Google Scholar

41 

Adeegbe DO and Nishikawa H: Natural and induced T regulatory cells in cancer. Front Immunol. 4(190)2013.PubMed/NCBI View Article : Google Scholar

42 

Weng L, Cao X, Han L, Zhao H, Qiu S, Yan Y, Wang X, Chen X, Zheng W, Xu X, et al: Association of increased Treg and Th17 with pathogenesis of moyamoya disease. Sci Rep. 7(3071)2017.PubMed/NCBI View Article : Google Scholar

43 

Wang CM, Luo Y, Wang YC and Sheng GY: Roles of follicular helper T cells and follicular regulatory T cells in pathogenesis of Henoch-Schönlein purpura in children. Zhongguo Dang Dai Er Ke Za Zhi. 17:1084–1087. 2015.PubMed/NCBI(In Chinese).

44 

Yang YH, Lai HJ, Huang CM, Wang LC, Lin YT and Chiang BL: Sera from children with active Henoch-Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells. Ann Rheum Dis. 63:1511–1513. 2004.PubMed/NCBI View Article : Google Scholar

45 

Yang YH, Huang YH, Lin YL, Wang LC, Chuang YH, Yu HH, Lin YT and Chiang BL: Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway. Clin Exp Immunol. 144:247–253. 2006.PubMed/NCBI View Article : Google Scholar

46 

Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, Monteiro RC and Van Egmond M: New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura). Autoimmun Rev. 16:1246–1253. 2017.PubMed/NCBI View Article : Google Scholar

47 

Wu JJ, Zhu YT and Hu YM: Mechanism of feedback regulation of neutrophil inflammation in Henoch-Schönlein purpura. Eur Rev Med Pharmacol Sci. 20:4277–4285. 2016.PubMed/NCBI

48 

Ray PD, Huang BW and Tsuji Y: Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 24:981–990. 2012.PubMed/NCBI View Article : Google Scholar

49 

Schieber M and Chandel NS: ROS function in redox signaling and oxidative stress. Curr Biol. 24:R453–R462. 2014.PubMed/NCBI View Article : Google Scholar

50 

Cesselli D, Aleksova A, Sponga S, Cervellin C, Di Loreto C, Tell G and Beltrami AP: Cardiac cell senescence and redox signaling. Front Cardiovasc Med. 4(38)2017.PubMed/NCBI View Article : Google Scholar

51 

Ciccarese F, Raimondi V, Sharova E, Silic-Benussi M and Ciminale V: Nanoparticles as tools to target redox homeostasis in cancer cells. Antioxidants (Basel). 9(211)2020.PubMed/NCBI View Article : Google Scholar

52 

Nakai K and Tsuruta D: What are reactive oxygen species, free radicals, and oxidative stress in skin diseases? Int J Mol Sci. 22(10799)2021.PubMed/NCBI View Article : Google Scholar

53 

Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E, Rajkovic J, Tsouh Fokou PV, Azzini E, Peluso I, et al: Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front Physiol. 11(694)2020.PubMed/NCBI View Article : Google Scholar

54 

Li Y and Pagano PJ: Microvascular NADPH oxidase in health and disease. Free Radic Biol Med. 109:33–47. 2017.PubMed/NCBI View Article : Google Scholar

55 

Schröder K: NADPH oxidases: Current aspects and tools. Redox Biol. 34(101512)2020.PubMed/NCBI View Article : Google Scholar

56 

Murphy MP: How mitochondria produce reactive oxygen species. Biochem J. 417:1–13. 2009.PubMed/NCBI View Article : Google Scholar

57 

Arazi H, Eghbali E and Suzuki K: Creatine supplementation, physical exercise and oxidative stress markers: A review of the mechanisms and effectiveness. Nutrients. 13(869)2021.PubMed/NCBI View Article : Google Scholar

58 

Kim YW, West XZ and Byzova TV: Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl). 91:323–328. 2013.PubMed/NCBI View Article : Google Scholar

59 

Salazar G: NADPH Oxidases and mitochondria in vascular senescence. Int J Mol Sci. 19(1327)2018.PubMed/NCBI View Article : Google Scholar

60 

Zhu Y, Dong Y, Xu DL, Jiang JY, Wu L, Ke RJ, Fang SH and Peng Y: Clinical effect and mechanism of hemoperfusion in treatment of children with severe abdominal Henoch-Schönlein purpura. Zhongguo Dang Dai Er Ke Za Zhi. 20:378–382. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).

61 

Gurses D, Parlaz N, Bor-Kucukatay M, Kucukatay V and Erken G: Evaluation of oxidative stress and erythrocyte properties in children with henoch-shoenlein purpura. Iran J Pediatr. 24:166–172. 2014.PubMed/NCBI

62 

Ece A, Kelekçi S, Kocamaz H, Hekimoğlu A, Balik H, Yolbaş I and Erel O: Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura. Clin Rheumatol. 27:163–169. 2008.PubMed/NCBI View Article : Google Scholar

63 

Higashi Y, Maruhashi T, Noma K and Kihara Y: Oxidative stress and endothelial dysfunction: Clinical evidence and therapeutic implications. Trends Cardiovasc Med. 24:165–169. 2014.PubMed/NCBI View Article : Google Scholar

64 

Mai J, Virtue A, Shen J, Wang H and Yang XF: An evolving new paradigm: Endothelial cells-conditional innate immune cells. J Hematol Oncol. 6(61)2013.PubMed/NCBI View Article : Google Scholar

65 

Hou X, Yang S and Yin J: Blocking the REDD1/TXNIP axis ameliorates LPS-induced vascular endothelial cell injury through repressing oxidative stress and apoptosis. Am J Physiol Cell Physiol. 316:C104–C110. 2019.PubMed/NCBI View Article : Google Scholar

66 

Wu H, Wen Y, Yue C, Li X and Gao R: Serum TNF-α level is associated with disease severity in adult patients with immunoglobulin a vasculitis nephritis. Dis Markers. 2020(5514145)2020.PubMed/NCBI View Article : Google Scholar

67 

Yuan P, Bo Y, Ming G, Wen-Jun F, Qin Z and Bo H: Apoptosis of human umbilical vein endothelial cells (HUVEC) induced by IgA1 isolated from Henoch-Schonlein purpura children. Asian Pac J Allergy Immunol. 32:34–38. 2014.PubMed/NCBI View Article : Google Scholar

68 

Montezano AC and Touyz RM: Reactive oxygen species and endothelial function-role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin Pharmacol Toxicol. 110:87–94. 2012.PubMed/NCBI View Article : Google Scholar

69 

Elalfy MS, Elhenawy YI, Deifalla S, Hegazy M, Sabra A and Abdelaziz Y: Oxidant/antioxidant status in children and adolescents with immune thrombocytopenia (ITP) and the role of an adjuvant antioxidant therapy. Pediatr Blood Cancer. 62:830–837. 2015.PubMed/NCBI View Article : Google Scholar

70 

Carta S, Semino C, Sitia R and Rubartelli A: Dysregulated IL-1β secretion in autoinflammatory diseases: A matter of stress? Front Immunol. 8(345)2017.PubMed/NCBI View Article : Google Scholar

71 

Noval Rivas M, Wakita D, Franklin MK, Carvalho TT, Abolhesn A, Gomez AC, Fishbein MC, Chen S, Lehman TJ, Sato K, et al: Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation. Immunity. 51:508–521.e6. 2019.PubMed/NCBI View Article : Google Scholar

72 

Sugino H, Sawada Y and Nakamura M: IgA Vasculitis: Etiology, treatment, biomarkers and epigenetic changes. Int J Mol Sci. 22(7538)2021.PubMed/NCBI View Article : Google Scholar

73 

Lavieri R, Piccioli P, Carta S, Delfino L, Castellani P and Rubartelli A: TLR costimulation causes oxidative stress with unbalance of proinflammatory and anti-inflammatory cytokine production. J Immunol. 192:5373–5381. 2014.PubMed/NCBI View Article : Google Scholar

74 

Gong L, Lei Y, Liu Y, Tan F, Li S, Wang X, Xu M, Cai W, Du B, Xu F, et al: Vaccarin prevents ox-LDL-induced HUVEC EndMT, inflammation and apoptosis by suppressing ROS/p38 MAPK signaling. Am J Transl Res. 11:2140–2154. 2019.PubMed/NCBI

75 

Duan T, Du Y, Xing C, Wang HY and Wang RF: Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 13(812774)2022.PubMed/NCBI View Article : Google Scholar

76 

Aluri J, Cooper MA and Schuettpelz LG: Toll-Like receptor signaling in the establishment and function of the immune system. Cells. 10(1374)2021.PubMed/NCBI View Article : Google Scholar

77 

Vijay K: Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. Int Immunopharmacol. 59:391–412. 2018.PubMed/NCBI View Article : Google Scholar

78 

Kuzmich NN, Sivak KV, Chubarev VN, Porozov YB, Savateeva-Lyubimova TN and Peri F: TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines (Basel). 5(34)2017.PubMed/NCBI View Article : Google Scholar

79 

Yao C, Oh JH, Lee DH, Bae JS, Jin CL, Park CH and Chung JH: Toll-like receptor family members in skin fibroblasts are functional and have a higher expression compared to skin keratinocytes. Int J Mol Med. 35:1443–1450. 2015.PubMed/NCBI View Article : Google Scholar

80 

Krishnan JS, KSelvarajoo K, Tsuchiya M, Lee G and Choi S: Toll-like receptor signal transduction. Exp Mol Med. 39:421–438. 2007.PubMed/NCBI View Article : Google Scholar

81 

Rong Z, Huang Y, Cai H, Chen M, Wang H, Liu G, Zhang Z and Wu J: Gut microbiota disorders promote inflammation and aggravate spinal cord injury through the TLR4/MyD88 signaling pathway. Front Nutr. 8(702659)2021.PubMed/NCBI View Article : Google Scholar

82 

Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K and Akira S: TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol. 4:1144–1150. 2003.PubMed/NCBI View Article : Google Scholar

83 

Mills KH: TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol. 11:807–822. 2011.PubMed/NCBI View Article : Google Scholar

84 

Park HS, Jung HY, Park EY, Kim J, Lee WJ and Bae YS: Cutting edge: Direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol. 173:3589–3593. 2004.PubMed/NCBI View Article : Google Scholar

85 

Gill R, Tsung A and Billiar T: Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med. 48:1121–1132. 2010.PubMed/NCBI View Article : Google Scholar

86 

Rauf A, Imran M, Abu-Izneid T, Iahtisham-Ul-Haq Patel S, Pan X, Naz S, Sanches Silva A, Saeed F and Rasul Suleria HA: Proanthocyanidins: A comprehensive review. Biomed Pharmacother. 116(108999)2019.PubMed/NCBI View Article : Google Scholar

87 

Bensa M, Glavnik V and Vovk I: Leaves of Invasive Plants-Japanese, bohemian and giant knotweed-the promising new nource of Flavan-3-ols and proanthocyanidins. Plants (Basel). 9(118)2020.PubMed/NCBI View Article : Google Scholar

88 

González-Quilen C, Rodríguez-Gallego E, Beltrán-Debón R, Pinent M, Ardévol A, Blay MT and Terra X: Health-promoting properties of proanthocyanidins for intestinal dysfunction. Nutrients. 12(130)2020.PubMed/NCBI View Article : Google Scholar

89 

Li S, Xu M, Niu Q, Xu S, Ding Y, Yan Y, Guo S and Li F: Efficacy of procyanidins against in vivo cellular oxidative damage: A systematic review and meta-analysis. PLoS One. 10(e0139455)2015.PubMed/NCBI View Article : Google Scholar

90 

Ravindranathan P, Pasham D, Balaji U, Cardenas J, Gu J, Toden S and Goel A: Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer. Carcinogenesis. 39:767–777. 2018.PubMed/NCBI View Article : Google Scholar

91 

Nawrot-Hadzik I, Matkowski A, Kubasiewicz-Ross P and Hadzik J: Proanthocyanidins and Flavan-3-ols in the prevention and treatment of periodontitis-immunomodulatory effects, animal and clinical Studies. Nutrients. 13(239)2021.PubMed/NCBI View Article : Google Scholar

92 

Odai T, Terauchi M, Kato K, Hirose A and Miyasaka N: Effects of grape seed proanthocyanidin extract on vascular endothelial function in participants with prehypertension: A randomized, double-blind, placebo-controlled study. Nutrients. 11(2844)2019.PubMed/NCBI View Article : Google Scholar

93 

Zhang R, Kang X, Liu L, Wang X, Li H, Zhu J, Cao Y and Zhu H: Gut microbiota modulation by plant polyphenols in koi carp (Cyprinus carpio L.). Front Microbiol. 13(977292)2022.PubMed/NCBI View Article : Google Scholar

94 

Suo H, Tian R, Li J, Zhang S, Cui Y, Li L and Sun B: Compositional characterization study on high-molecular-mass polymeric polyphenols in red wines by chemical degradation. Food Res Int. 123:440–449. 2019.PubMed/NCBI View Article : Google Scholar

95 

Yuan L, Wang Q, Zhang S and Zhang L: Correlation between serum inflammatory factors TNF-α, IL-8, IL-10 and Henoch-Schonlein purpura with renal function impairment. Exp Ther Med. 15:3924–3928. 2018.PubMed/NCBI View Article : Google Scholar

96 

Park MK, Park JS, Cho ML, Oh HJ, Heo YJ, Woo YJ, Heo YM, Park MJ, Park HS, Park SH, et al: Grape seed proanthocyanidin extract (GSPE) differentially regulates Foxp3(+) regulatory and IL-17(+) pathogenic T cell in autoimmune arthritis. Immunol Lett. 135:50–58. 2011.PubMed/NCBI View Article : Google Scholar

97 

Jhun JY, Moon SJ, Yoon BY, Byun JK, Kim EK, Yang EJ, Ju JH, Hong YS, Min JK, Park SH, et al: Grape seed proanthocyanidin extract-mediated regulation of STAT3 proteins contributes to Treg differentiation and attenuates inflammation in a murine model of obesity-associated arthritis. PLoS One. 8(e78843)2013.PubMed/NCBI View Article : Google Scholar

98 

Park IJ, Cha SY, Kang M, So YS, Go HG, Mun SP, Ryu KS and Jang HK: Effect of proanthocyanidin-rich extract from Pinus radiata bark on immune response of specific-pathogen-free White Leghorn chickens. Poult Sci. 90:977–982. 2011.PubMed/NCBI View Article : Google Scholar

99 

Min HK, Kim SM, Baek SY, Woo JW, Park JS, Cho ML, Lee J, Kwok SK, Kim SW and Park SH: Anthocyanin extracted from black soybean seed coats prevents autoimmune arthritis by suppressing the development of Th17 cells and synthesis of proinflammatory cytokines by such cells, via inhibition of NF-κB. PLoS One. 10(e0138201)2015.PubMed/NCBI View Article : Google Scholar

100 

Takano F, Takata T, Yoshihara A, Nakamura Y, Arima Y and Ohta T: Aqueous extract of peanut skin and its main constituent procyanidin A1 suppress serum IgE and IgG1 levels in mice-immunized with ovalbumin. Biol Pharm Bull. 30:922–927. 2007.PubMed/NCBI View Article : Google Scholar

101 

Long M, Yang SH, Han JX, Li P, Zhang Y, Dong S, Chen X, Guo J, Wang J and He JB: The protective effect of grape-seed proanthocyanidin extract on oxidative damage induced by zearalenone in kunming mice liver. Int J Mol Sci. 17(808)2016.PubMed/NCBI View Article : Google Scholar

102 

Han S, Gao H, Chen S, Wang Q, Li X, Du LJ, Li J, Luo YY, Li JX, Zhao LC, et al: Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells. Sci Rep. 9(15087)2019.PubMed/NCBI View Article : Google Scholar

103 

Katiyar SK: Proanthocyanidins from grape seeds inhibit UV-radiation-induced immune suppression in mice: Detection and analysis of molecular and cellular targets. Photochem Photobiol. 91:156–162. 2015.PubMed/NCBI View Article : Google Scholar

104 

Kim SH, Bang J, Son CN, Baek WK and Kim JM: Grape seed proanthocyanidin extract ameliorates murine autoimmune arthritis through regulation of TLR4/MyD88/NF-κB signaling pathway. Korean J Intern Med. 33:612–621. 2018.PubMed/NCBI View Article : Google Scholar

105 

El-Shitany NA and Eid B: Proanthocyanidin protects against cisplatin-induced oxidative liver damage through inhibition of inflammation and NF-κβ/TLR-4 pathway. Environ Toxicol. 32:1952–1963. 2017.PubMed/NCBI View Article : Google Scholar

106 

Mittal A, Elmets CA and Katiyar SK: Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: Relationship to decreased fat and lipid peroxidation. Carcinogenesis. 24:1379–1388. 2003.PubMed/NCBI View Article : Google Scholar

107 

Rodríguez RM, Colom-Pellicer M, Blanco J, Calvo E, Aragonès G and Mulero M: Grape-Seed procyanidin extract (GSPE) Seasonal-Dependent modulation of glucose and lipid metabolism in the liver of healthy F344 rats. Biomolecules. 12(839)2022.PubMed/NCBI View Article : Google Scholar

108 

Sharma SD, Meeran SM and Katiyar SK: Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor-kappaB signaling in in vivo SKH-1 hairless mice. Mol Cancer Ther. 6:995–1005. 2007.PubMed/NCBI View Article : Google Scholar

109 

Divya SP, Wang X, Pratheeshkumar P, Son YO, Roy RV, Kim D, Dai J, Hitron JA, Wang L, Asha P, et al: Blackberry extract inhibits UVB-induced oxidative damage and inflammation through MAP kinases and NF-κB signaling pathways in SKH-1 mice skin. Toxicol Appl Pharmacol. 284:92–99. 2015.PubMed/NCBI View Article : Google Scholar

110 

Ma X, Wang R, Yu S, Lu G, Yu Y and Jiang C: Anti-Inflammatory activity of oligomeric proanthocyanidins via inhibition of NF-κB and MAPK in LPS-Stimulated MAC-T Cells. J Microbiol Biotechnol. 30:1458–1466. 2020.PubMed/NCBI View Article : Google Scholar

111 

Rajput SA, Sun L, Zhang NY, Khalil MM, Ling Z, Chong L, Wang S, Rajput IR, Bloch DM, Khan FA, et al: Grape seed proanthocyanidin extract alleviates aflatoxin B1-induced immunotoxicity and oxidative stress via modulation of NF-κB and Nrf2 signaling pathways in broilers. Toxins (Basel). 11(23)2019.PubMed/NCBI View Article : Google Scholar

112 

Jia Z, Song Z, Zhao Y, Wang X and Liu P: Grape seed proanthocyanidin extract protects human lens epithelial cells from oxidative stress via reducing NF-кB and MAPK protein expression. Mol Vis. 17:210–217. 2011.PubMed/NCBI

113 

Schmuch J, Beckert S, Brandt S, Löhr G, Hermann F, Schmidt TJ, Beikler T and Hensel A: Extract from Rumex acetosa L. for prophylaxis of periodontitis: Inhibition of bacterial in vitro adhesion and of gingipains of Porphyromonas gingivalis by epicatechin-3-O-(4β→8)-epicatechin-3-O-gallate (procyanidin-B2-Di-gallate). PLoS One. 10(e0120130)2015.PubMed/NCBI View Article : Google Scholar

114 

Steffen Y, Gruber C, Schewe T and Sies H: Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys. 469:209–219. 2008.PubMed/NCBI View Article : Google Scholar

115 

Álvarez E, Rodiño-Janeiro BK, Jerez M, Ucieda-Somoza R, Núñez MJ and González-Juanatey JR: Procyanidins from grape pomace are suitable inhibitors of human endothelial NADPH oxidase. J Cell Biochem. 113:1386–1396. 2012.PubMed/NCBI View Article : Google Scholar

116 

Pinna C, Morazzoni P and Sala A: Proanthocyanidins from Vitis vinifera inhibit oxidative stress-induced vascular impairment in pulmonary arteries from diabetic rats. Phytomedicine. 25:39–44. 2017.PubMed/NCBI View Article : Google Scholar

117 

Weseler AR and Bast A: Masquelier's grape seed extract: From basic flavonoid research to a well-characterized food supplement with health benefits. Nutr J. 16(5)2017.PubMed/NCBI View Article : Google Scholar

118 

Yang LJ, Zhu DN, Dang YL and Zhao X: Treatment of condyloma acuminata in pregnant women with cryotherapy combined with proanthocyanidins: Outcome and safety. Exp Ther Med. 11:2391–2394. 2016.PubMed/NCBI View Article : Google Scholar

119 

Sano A: Safety assessment of 4-week oral intake of proanthocyanidin-rich grape seed extract in healthy subjects. Food Chem Toxicol. 108:519–523. 2017.PubMed/NCBI View Article : Google Scholar

120 

Occhipinti A, Germano A and Maffei ME: Prevention of urinary tract infection with oximacro, a cranberry extract with a high content of A-type proanthocyanidins: A pre-clinical double-blind controlled study. Urol J. 13:2640–2649. 2016.PubMed/NCBI

121 

Serrano J, Casanova-Martí À, Gil-Cardoso K, Blay MT, Terra X, Pinent M and Ardévol A: Acutely administered grape-seed proanthocyanidin extract acts as a satiating agent. Food Funct. 7:483–490. 2016.PubMed/NCBI View Article : Google Scholar

122 

Zhao Y, Xie Y, Li X, Song J, Guo M, Xian D and Zhong J: The protective effect of proanthocyanidins on the psoriasis-like cell models via PI3K/AKT and HO-1. Redox Rep. 27:200–211. 2022.PubMed/NCBI View Article : Google Scholar

123 

Omma A, Colak S, Can Sandikci S, Yucel C, Erden A, Sertoglu E and Ozgurtas T: Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch-Schönlein purpura). Int J Rheum Dis. 22:1920–1925. 2019.PubMed/NCBI View Article : Google Scholar

124 

Wang B, Shao-Kuan FR and Dong C: Expression and significance of follicular helper T cells and galactose-deficient IgA1 in children with Henoch-Schönlein purpura. Zhongguo Dang Dai Er Ke Za Zhi. 22:473–477. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).

125 

Long M, Zhang Y, Li P, Yang SH, Zhang WK, Han JX, Wang Y and He JB: Intervention of Grape seed proanthocyanidin extract on the subchronic immune injury in mice induced by Aflatoxin B1. Int J Mol Sci. 17(516)2016.PubMed/NCBI View Article : Google Scholar

126 

Liu X, Qiu J, Zhao S, You B, Ji X, Wang Y, Cui X, Wang Q and Gao H: Grape seed proanthocyanidin extract alleviates ouabain-induced vascular remodeling through regulation of endothelial function. Mol Med Rep. 6:949–954. 2012.PubMed/NCBI View Article : Google Scholar

127 

Di Pietro GM, Castellazzi ML, Mastrangelo A, Montini G, Marchisio P and Tagliabue C: Henoch-Schönlein Purpura in children: Not only kidney but also lung. Pediatr Rheumatol Online J. 17(75)2019.PubMed/NCBI View Article : Google Scholar

128 

Padeh S and Passwell JH: Successful treatment of chronic Henoch-Schonlein purpura with colchicine and aspirin. Isr Med Assoc J. 2:482–483. 2000.PubMed/NCBI

129 

Pan S and Zhong J: Construction and identification of simplified rat model of Henoch-Schönlein Purpura. Sichuan Med J. 42:669–672. 2021.(In Chinese).

130 

Li Y, Feng X, Huang L, Zhu H, Xu Y, Sui X, Xu Y, Han Y and Qin C: Hematologic and immunological characteristics of Henoch-Schönlein purpura in rat and rabbit models induced with ovalbumin based on type III hypersensitivity. Sci Rep. 5(8862)2015.PubMed/NCBI View Article : Google Scholar

131 

Kaegi C, Wuest B, Schreiner J, Steiner UC, Vultaggio A, Matucci A, Crowley C and Boyman O: Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders. Front Immunol. 10(1990)2019.PubMed/NCBI View Article : Google Scholar

132 

Gohari A, Matsell DG, Mammen C and Goldman RD: Henoch-Schönlein purpura in children: Use of corticosteroids for prevention and treatment of renal disease. Can Fam Physician. 66:895–897. 2020.PubMed/NCBI View Article : Google Scholar

133 

Du Y, Hou L, Zhao C, Han M and Wu Y: Treatment of children with Henoch-Schönlein purpura nephritis with mycophenolate mofetil. Pediatr Nephrol. 27:765–771. 2012.PubMed/NCBI View Article : Google Scholar

134 

Nikibakhsh AA, Mahmoodzadeh H, Karamyyar M, Hejazi S, Noroozi M, Macooie AA, Gholizadeh A and Gholizadeh L: Treatment of complicated henoch-schönlein purpura with mycophenolate mofetil: A retrospective case series report. Int J Rheumatol. 2010(254316)2010.PubMed/NCBI View Article : Google Scholar

135 

Fujimoto M, Katayama K, Nishikawa K, Mizoguchi S, Oda K, Hirabayashi Y, Suzuki Y, Haruki A, Ito T, Murata T, et al: A Kidney transplant recipient with recurrent Henoch-Schönlein Purpura nephritis successfully treated with steroid pulse therapy and epipharyngeal abrasive therapy. Nephron. 144 (Suppl 1):S54–S48. 2020.PubMed/NCBI View Article : Google Scholar

136 

Kurnia B: Henoch-Schonlein purpura in children: The role of corticosteroids. Open Access Maced J Med Sci. 7:1812–1814. 2019.PubMed/NCBI View Article : Google Scholar

137 

Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, et al: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 58:1607–1616. 2019.PubMed/NCBI View Article : Google Scholar

138 

Han F, Chen LL, Ren PP, Le JY, Choong PJ, Wang HJ, Xu Y and Chen JH: Mycophenolate mofetil plus prednisone for inducing remission of Henoch-Schönlein purpura nephritis: A retrospective study. J Zhejiang Univ Sci B. 16:772–779. 2015.PubMed/NCBI View Article : Google Scholar

139 

Lu Z, Song J, Mao J, Xia Y and Wang C: Evaluation of mycophenolate mofetil and Low-dose steroid combined therapy in moderately severe Henoch-Schönlein Purpura nephritis. Med Sci Monit. 23:2333–2339. 2017.PubMed/NCBI View Article : Google Scholar

140 

Hamilton P, Ogundare O, Raza A, Ponnusamy A, Gorton J, Alachkar H, Choudhury J, Barratt J and Kalra PA: Long-term therapeutic plasma exchange to prevent End-stage kidney disease in adult severe resistant Henoch-Schonlein purpura nephritis. Case Rep Nephrol. 2015(269895)2015.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xie Y, Deng Q, Guo M, Li X, Xian D and Zhong J: Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review). Exp Ther Med 25: 300, 2023.
APA
Xie, Y., Deng, Q., Guo, M., Li, X., Xian, D., & Zhong, J. (2023). Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review). Experimental and Therapeutic Medicine, 25, 300. https://doi.org/10.3892/etm.2023.11999
MLA
Xie, Y., Deng, Q., Guo, M., Li, X., Xian, D., Zhong, J."Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review)". Experimental and Therapeutic Medicine 25.6 (2023): 300.
Chicago
Xie, Y., Deng, Q., Guo, M., Li, X., Xian, D., Zhong, J."Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review)". Experimental and Therapeutic Medicine 25, no. 6 (2023): 300. https://doi.org/10.3892/etm.2023.11999
Copy and paste a formatted citation
x
Spandidos Publications style
Xie Y, Deng Q, Guo M, Li X, Xian D and Zhong J: Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review). Exp Ther Med 25: 300, 2023.
APA
Xie, Y., Deng, Q., Guo, M., Li, X., Xian, D., & Zhong, J. (2023). Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review). Experimental and Therapeutic Medicine, 25, 300. https://doi.org/10.3892/etm.2023.11999
MLA
Xie, Y., Deng, Q., Guo, M., Li, X., Xian, D., Zhong, J."Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review)". Experimental and Therapeutic Medicine 25.6 (2023): 300.
Chicago
Xie, Y., Deng, Q., Guo, M., Li, X., Xian, D., Zhong, J."Proanthocyanidins: A novel approach to Henoch‑Schonlein purpura through balancing immunity and arresting oxidative stress via TLR4/MyD88/NF‑κB signaling pathway (Review)". Experimental and Therapeutic Medicine 25, no. 6 (2023): 300. https://doi.org/10.3892/etm.2023.11999
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team